MAPT and Alzheimer disease: While α-syn aggregate levels did not differbetween AD andcontrol (Figure 4B,C),there was a trend for higher Aβ (Figure 4D) and total tau (Figure 4E) in the CSF biomarker positive cases accompaniedby significantly higher levels of AT8-positive tau aggregates (Figure 4D).